Peptides · Peptide comparison
Lactoferricin B vs Thymalin
A 25-amino-acid antimicrobial peptide fragment derived from bovine lactoferrin by pepsin cleavage, featuring a twisted antiparallel beta-sheet structure with broad-spectrum bactericidal activity, anti-biofilm properties, and emerging anticancer potential through selective membrane disruption mediated by the critical RRWQWR motif
Russian thymic peptide complex that rejuvenates immune function and supports healthy aging
- Immune
- Immune
At a glance
Quick comparison
Efficacy
Benefit ratings
Fighting Germs
Cancer Cell Targeting
Immune Support
Immune Restoration
Longevity Support
Disease Prevention
Technical data
Compound specifications
Lactoferricin B
- Molecular formula
- Approximately C142H224N46O34S2 (varies slightly by reported sequence)
- Molecular weight
- ~3,126 Da (25-amino-acid bovine lactoferricin B)
- Half-life
- Plasma half-life: minutes (proteolytic degradation); gastrointestinal persistence: hours (relative resistance to trypsin and chymotrypsin compared to unstructured peptides); beta-sheet structure and disulfide bond provide moderate protease resistance
- Bioavailability
- Generated endogenously during gastric digestion of dietary lactoferrin; partially resistant to further proteolytic degradation due to beta-sheet structure and disulfide bond; systemic bioavailability limited by intestinal proteases and hepatic metabolism
- CAS number
- 146897-68-9
Thymalin
- Molecular formula
- Complex mixture; active dipeptide EW: C16H19N3O5
- Molecular weight
- Polypeptide complex; components 250-1000 Da; active dipeptide EW ~321 Da
- Half-life
- Not precisely characterized for complex; immune effects persist weeks post-administration
- Bioavailability
- High via intramuscular or subcutaneous injection
- CAS number
- 63958-90-7
Protocols
Dosing compared
Lactoferricin B
No dose levels recorded.
Thymalin
Intramuscular injection
- 5-10 mg reconstituted in salineOnce daily · 5-10 day course, often repeated every 6 monthsReflects the Russian clinical course used in immune-restoration and gerontology protocols, typically 10 mg IM daily for 5-10 days [1].
Subcutaneous injection
- 10 mgOnce daily · Up to 20 day course, repeated every 6 monthsSubcutaneous administration is used in community practice at the same 10 mg daily dosing; longer 20-day courses are described for cyclical immune support [1].
Applications
Best suited for
Lactoferricin B
- Research into dairy-derived antimicrobial peptides and natural innate defense mechanisms
- Lactoferricin B is particularly well-suited for individuals focused on research into dairy-derived antimicrobial peptides and natural innate defense mechanisms. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Investigation of structure-activity relationships in beta-sheet antimicrobial peptides
- Lactoferricin B is particularly well-suited for individuals focused on investigation of structure-activity relationships in beta-sheet antimicrobial peptides. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Preclinical development of anticancer peptides targeting membrane phospholipid asymmetry
- Lactoferricin B is particularly well-suited for individuals focused on preclinical development of anticancer peptides targeting membrane phospholipid asymmetry. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Understanding the gastrointestinal antimicrobial defense provided by dietary lactoferrin digestion
- Lactoferricin B is particularly well-suited for individuals focused on understanding the gastrointestinal antimicrobial defense provided by dietary lactoferrin digestion. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Thymalin
- Aging Adults Seeking Immune Support
- Thymalin is especially valuable for people over 55 whose thymus gland has naturally shrunk with age. By stimulating thymic function, it helps restore the immune training center that your body relies on to fight infections and stay healthy.
- Longevity and Anti-Aging Protocols
- Clinical studies tracking patients for 6-8 years showed Thymalin reduced mortality by 2.0-2.1-fold. Combined with Epitalon, the mortality reduction reached an impressive 4.1-fold, making this combination one of the most studied longevity peptide protocols.
- Seasonal Illness Prevention
- Research shows Thymalin cuts respiratory infection rates by 2.0-2.4-fold. A short 10-day course before cold and flu season can significantly boost your immune defenses for months afterward.
Safety profile
Side effects
Lactoferricin B
Common
- Mild GI discomfort
- Bitter taste
- Local irritation (topical use)
- Mild flatulence
Uncommon
- Allergic reaction in milk-sensitive individuals
Serious
- Hemolytic activity at high concentrations
Thymalin
Common
- No side effects in most patients
- Mild injection site reaction
Uncommon
- Transient low-grade fever
- Mild flu-like symptoms
- Temporary headache
Serious
- Severe allergic reaction
Research status
Safety & evidence
Lactoferricin B
- Evidence level
- Moderate human trials (Phase 1-2)
- FDA status
- Research compound
- Safety overview
- Lactoferricin B is a 25-amino acid peptide fragment of bovine lactoferrin, a protein found in cow's milk [2]. Preclinical studies show excellent tolerability with no hepatotoxicity, nephrotoxicity, or genotoxicity in animal models even at supraphysiological doses. The antimicrobial and antifungal mechanism (iron sequestration and membrane disruption) appears selective for pathogenic microorganisms with minimal effect on commensal bacteria at therapeutic concentrations.
Contraindications
- Known allergy to bovine milk proteins or lactoferrin — cross-reactivity possible
- Pregnancy and breastfeeding — insufficient safety data for therapeutic-dose lactoferricin supplementation
- Active hemolytic conditions — at higher concentrations lactoferricin shows some hemolytic activity that may worsen hemolysis
- Iron overload conditions (hemochromatosis) — lactoferricin retains some iron-binding capacity from the parent lactoferrin molecule
Thymalin
- Evidence level
- Limited human trials
- FDA status
- Research compound
- Safety overview
- Thymalin has an excellent safety profile based on over 40 years of clinical use in Russia. Most patients experience zero side effects, and the peptide complex has been described as 'practically non-toxic' in research literature. It has been used safely in thousands of patients, including elderly populations over extended periods.
Contraindications
- Active thymic tumors or malignancies
- Known hypersensitivity to animal-derived peptide products
- Pregnancy and breastfeeding (insufficient safety data)
- Severe uncontrolled autoimmune disease without medical supervision
Decision guide
Which is right for you?
Lactoferricin B
Choose Lactoferricin B if…
- Research into dairy-derived antimicrobial peptides and natural innate defense mechanisms
- Investigation of structure-activity relationships in beta-sheet antimicrobial peptides
- Preclinical development of anticancer peptides targeting membrane phospholipid asymmetry
- Understanding the gastrointestinal antimicrobial defense provided by dietary lactoferrin digestion
Thymalin
Choose Thymalin if…
- Immune system restoration in aging adults
- Longevity and healthy aging support
- Reducing infection frequency and severity
- Multi-system health optimization